CEOP-21 versus CEOP-14 chemotherapy with or without rituximab for the first-line treatment of patients with aggressive lymphomas: results of the HE22A99 trial of the Hellenic Cooperative Oncology Group.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples